Invitrogen™ Peptide synthétique LRRTM4 humain
LRRTM4 Synthetic Peptide, PEP-1215, from Invitrogen.
- Gene ID (Entrez)
- 80059
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- Q86VH4
- Nom usuel
- Human LRRTM4
- Marque
- Invitrogen
LRRTM4 Synthetic Peptide, PEP-1215, from Invitrogen.
LRRTM4 Synthetic Peptide, PEP-1215, from Invitrogen.
The Leucine-rich repeat transmembrane neuronal proteins (LRRTMs) are differentially expressed in the nervous system and were recently found to instruct presynaptic and mediate postsynaptic glutamatergic differentiation, with LRRTM1 and LRRTM2 most potent at inducing presynaptic differentiation. Little is known about the function of LRRTM4; in mouse, it is expressed in the limb mesenchyme, neural tube, caudal mesoderm and in three distinct regions of the head. Later expression occurs in a subset of the developing sclerotome. Its similarity to other LRRTM family members suggests that LRRTM4 may also play a role in the development and maintenance of the vertebrate nervous system.
Espèces : Humaine.
Conservation : -20°C.
Concentration : 200 μg/mL.
Réservé à la recherche (RUO).
Conditionnement : 50 μg.
| Général | |
|---|---|
| Marque | Invitrogen |
| Réf. fournisseur (Fisher Scientific) | 15225219 |
| Caractéristiques | |
| Gene ID (Entrez) | 80059 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q86VH4 |
| Nom usuel | Human LRRTM4 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | LRRTM4 |
| Lyophilisé | No |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Stockage et expédition | |
| Contenu et stockage | -20°C |
| Conservateur | 0.02% sodium azide |
| Tampon de stockage | PBS |
| Réf. fabricant | PEP-1215 |
|---|---|
| Pays d’origine | États-Unis |
| Code douanier (SH) | 3824 99 92 00 |